# A Randomized, Triple‐Blind, Placebo‐Controlled, Parallel Clinical Trial Investigating Safety and Efficacy of Corn Leaf Extract on Sleep Quality in a Healthy Population With Difficulty Falling or Staying Asleep

**Authors:** Katarina M. Doma, Abdelrahman Zamzam, David C. Crowley, Najla Guthrie, Erin D. Lewis

PMC · DOI: 10.1002/fsn3.71285 · Food Science & Nutrition · 2026-01-02

## TL;DR

A clinical trial found that corn leaf extract improves sleep quality and is safe for people with sleep difficulties.

## Contribution

Corn leaf extract (CLE) is shown to significantly improve sleep parameters in a healthy population with sleep issues.

## Key findings

- CLE supplementation increased total sleep time, REM sleep, and light sleep compared to placebo.
- Participants had fewer sleep interruptions and shorter sleep onset latency with CLE.
- CLE was safe and well tolerated over 28 days.

## Abstract

Difficulties falling and/or staying asleep affect over one quarter of adults in the United States. Current management strategies include prescription sleep aids. However, long‐term use is associated with serious adverse effects. Therefore, natural alternative sleep aids that may provide safer and more effective relief of sleep disturbances are needed. In this randomized, triple‐blind, placebo‐controlled clinical trial, 80 healthy adults (n = 40 per group) with difficulties falling and/or staying asleep were supplemented with a standardized corn leaf extract (CLE) or placebo for 28 days. Objective (actigraphy with electroencephalogram) and subjective (Pittsburgh Sleep Quality Index) sleep measures, serum serotonin, plasma melatonin, and gamma‐aminobutyric acid were assessed at baseline (Day 0), Day 14, and Day 28, and safety was assessed at screening and Day 28. Compared to placebo, participants supplemented with CLE demonstrated statistically significant increases in total sleep time (TST) and light sleep at Day 28 and improvements in REM sleep at both Days 14 and 28. Further, participants supplemented with CLE had significantly fewer sleep interruptions and shorter sleep onset latency at Day 14 with shorter wake after sleep onset (WASO) and higher sleep efficiency at Days 14 and 28. Post hoc analysis supported these findings with a significant increase of 35.7 min in non‐REM sleep at Day 28 for participants supplemented with CLE compared to a decrease of 10.6 min for those on placebo. Supplementation with CLE was safe and well tolerated. Findings suggest CLE supplementation may improve sleep parameters in a healthy population with sleep difficulties.

Corn leaf extract (CLE) contains a naturally occurring substance, 6‐methoxybenzoxazolinone (6‐MBOA). Structurally similar to melatonin, 6‐MBOA acts as a weak β‐adrenergic agonist with an affinity for melatonin receptors and stimulating melatonin synthesis. In a randomized, placebo‐controlled clinical trial of individuals with difficulty falling and/or staying asleep, CLE supplementation resulted in a significant increase in total, REM, and light sleep time, in comparison to placebo, as well as a reduction in sleep interruptions and shorter sleep onset latency.

## Linked entities

- **Chemicals:** 6-methoxybenzoxazolinone (PubChem CID 10772), melatonin (PubChem CID 896), gamma-aminobutyric acid (PubChem CID 119), serotonin (PubChem CID 5202)

## Full-text entities

- **Diseases:** interruptions (OMIM:217095), sleep difficulties (MESH:D012893)
- **Chemicals:** CLE (-), serotonin (MESH:D012701), melatonin (MESH:D008550), gamma-aminobutyric acid (MESH:D005680)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12759108/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12759108/full.md

## References

45 references — full list in the complete paper: https://tomesphere.com/paper/PMC12759108/full.md

---
Source: https://tomesphere.com/paper/PMC12759108